Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.

Saved in:
Bibliographic Details
Title: Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.
Authors: Green ML; Certara Strategic Consulting, Menlo Park, CA, USA., Ma SC; Certara Strategic Consulting, Menlo Park, CA, USA., Goble S; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Giordano H; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Maloney L; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Simmons AD; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Beltman J; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Harding TC; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA., Xiao JJ; Clovis Oncology, Inc., 5500 Flatiron Pkwy, Boulder, CO, 80301, USA. jxiao@clovisoncology.com.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 May; Vol. 89 (5), pp. 671-682. Date of Electronic Publication: 2022 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0843
DOI:10.1007/s00280-022-04413-7